State AZ
Clinical Trials in Arizona
Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 282 actively recruiting studies with Arizona sites out of 282 registered in total. The busiest research areas in Arizona are Heart Failure, Prostate Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include Mayo Clinic, AstraZeneca, University of Arizona. By stage, Arizona trials break down as Phase 1 (40), Phase 2 (91), Phase 3 (97), Phase 4 (11).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Arizona
Frequently Asked Questions — Clinical Trials in Arizona
How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 282 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 282. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Heart Failure, Prostate Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Arizona
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT07154290 Phase 2
Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adul...
Condition
Non Small Cell Lung Cancer
Enrollment
300 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
NCT07761117 Phase 3
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Ad...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment
6,950 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07654374 Phase 3
Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes...
Condition
Obesity
Enrollment
1,100 pts
Location
United States
Sponsor
Gasherbrum Bio, Inc., a wholly
NCT03959085 Phase 3
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With ...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
5,951 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06033950 Phase 3
Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With ...
Condition
Heart Failure
Enrollment
2,600 pts
Location
United States, Argentina, Brazil
Sponsor
Colorado Prevention Center
NCT05265273 Phase 2, Phase 3
Recruiting
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized...
Condition
Myasthenia Gravis
Enrollment
12 pts
Location
United States, Japan, Netherlands
Sponsor
Janssen Research & Development
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06952803 Phase 3
Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standar...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05908331 N/A
Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Condition
In-Stent Restenosis
Enrollment
492 pts
Location
United States
Sponsor
Concept Medical Inc.
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06535854 N/A
Recruiting
Prevail Global Study
Condition
Coronary Artery Disease
Enrollment
1,205 pts
Location
United States, Canada, Germany
Sponsor
Medtronic Vascular
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
175 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
NCT06962111 N/A
Recruiting
Early-Stage Partner in Care Living Alone Plus
Condition
Dementia
Enrollment
70 pts
Location
United States
Sponsor
Arizona State University
NCT01297400 Phase 2
Recruiting
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burn...
Condition
Burns
Enrollment
60 pts
Location
United States, Mexico
Sponsor
Skingenix, Inc.
NCT02074839 Phase 1
Recruiting
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malign...
Condition
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment
291 pts
Location
United States, France
Sponsor
Institut de Recherches Interna
NCT07775495 N/A
Recruiting
Observational Study of Decentralized Urine Optical Interaction Patterns Associat...
Condition
Healthy Adult Participants
Enrollment
15 pts
Location
United States
Sponsor
Ecotera Health LLC
NCT03701581 Phase 2, Phase 3
Recruiting
4-aminopyridine Treatment for Nerve Injury
Condition
Nerve Injury
Enrollment
70 pts
Location
United States
Sponsor
John Elfar
NCT07382167 Phase 3
Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopa...
Condition
Chronic Idiopathic Constipation (CIC)
Enrollment
692 pts
Location
United States
Sponsor
Ardelyx
NCT04953559 N/A
Recruiting
Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep
Condition
Insomnia, Primary
Enrollment
20 pts
Location
United States
Sponsor
University of Arizona
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
NCT07570654 Phase 2, Phase 3
Recruiting
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COM...
Condition
PTSD - Post Traumatic Stress Disorder
Enrollment
300 pts
Location
United States, Canada
Sponsor
COMPASS Pathways
NCT07365241 Phase 3
Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous...
Condition
Small Cell Lung Cancer
Enrollment
531 pts
Location
United States, Austria, Belgium
Sponsor
AbbVie
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology